Opko Health OPK Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Gross Profit by Business | ||||||
| Diagnostics | $16.04M+45.3% | $11.04M-25.6% | $14.84M-20.7% | $18.72M+2.1% | $18.33M-31.6% | |
| Pharmaceutical | $29.71M-43.9% | $52.99M+51.2% | $35.05M+14.2% | $30.68M+26.3% | $24.29M-58.0% | |
| Operating Income by Business | ||||||
| Diagnostics | -$12.95M— | —— | $81.63M+549% | -$18.16M+24.1% | -$23.92M-10.3% | |
| Pharmaceutical | -$29.68M-178% | -$10.68M+55.8% | -$24.19M+15.7% | -$28.71M+17.4% | -$34.77M-1,557% | |
| Total Assets by Business | ||||||
| Diagnostics | $343.37M-1.6% | $349.1M-7.4% | $376.99M-20.8% | $476.22M-1.3% | $482.67M-2.3% | |
| Pharmaceutical | $1.3B-1.8% | $1.33B+0.3% | $1.32B-1.5% | $1.34B— | —— | |
| Selling General And Administrative Expense by Business | ||||||
| Diagnostics | $26.15M-1.2% | $26.47M-16.0% | $31.5M-5.6% | $33.37M-12.1% | $37.96M-13.7% | |
| Pharmaceutical | $14.21M-4.7% | $14.9M+14.1% | $13.06M-1.1% | $13.2M+3.8% | $12.71M-7.5% | |
| Research And Development Expense by Business | ||||||
| Diagnostics | $312K-4.3% | $326K+12.8% | $289K-40.3% | $484K-10.0% | $538K+1.5% | |
| Pharmaceutical | $28.75M-10.8% | $32.25M+8.8% | $29.64M-0.4% | $29.78M-1.5% | $30.24M+1.3% | |
| D&A by Business | ||||||
| Diagnostics | $3.93M-4.0% | $4.09M-13.0% | $4.7M-3.8% | $4.89M-14.3% | $5.7M-4.7% | |
| Pharmaceutical | $18.26M-0.1% | $18.28M+1.3% | $18.04M-0.6% | $18.14M+2.0% | $17.79M-1.5% | |
| Goodwill by Business | ||||||
| Diagnostics | $163.44M0.0% | $163.44M0.0% | $163.44M0.0% | $163.44M0.0% | $163.44M-25.6% | |
| Pharmaceutical | $318.83M-0.6% | $320.85M+0.1% | $320.59M0.0% | $320.74M— | —— | |
| Cost of Goods Sold by Business | ||||||
| Diagnostics | $56.14M-6.5% | $60.05M-25.3% | $80.4M-2.4% | $82.38M-2.5% | $84.52M+10.8% | |
| Pharmaceutical | $22.3M-8.5% | $24.38M+14.1% | $21.37M-14.6% | $25.02M+9.7% | $22.81M+0.6% | |
| Amortization Of Intangible Assets by Business | ||||||
| Diagnostics | $2.53M0.0% | $2.53M-15.3% | $2.99M-1.2% | $3.03M-19.2% | $3.75M-5.6% | |
| Pharmaceutical | $16.43M-0.5% | $16.52M-0.1% | $16.54M+0.8% | $16.42M+1.9% | $16.11M-1.6% | |
| Goodwill Foreign Currency Translation Gain Loss by Business | ||||||
| Diagnostics | $0— | $0— | $0— | $0— | $0— | |
| Pharmaceutical | -$1.76M-8,091% | $22K— | —— | —— | —— | |
| Goodwill Impaired Accumulated Impairment Loss by Business | ||||||
| Diagnostics | $17.98M0.0% | $17.98M0.0% | $17.98M0.0% | $17.98M0.0% | $17.98M0.0% | |
| Pharmaceutical | $11.7M0.0% | $11.7M0.0% | $11.7M0.0% | $11.7M— | —— | |
| Revenue by Product | ||||||
| Intellectual Property And Other | $14M— | —— | $18.7M+24.7% | $15M+22.0% | $12.3M— | |
| Rayaldee | $12.81M-24.1% | $16.87M+13.4% | $14.88M+2.4% | $14.53M+10.8% | $13.11M-34.0% | |
| Transfer Of Intellectual Property And Other | $13.97M-58.6% | $33.72M+79.9% | $18.75M+25.3% | $14.96M+22.0% | $12.27M-71.6% | |
| Cost of Goods Sold by Product | ||||||
| Product | $22.3M-8.5% | $24.38M+14.1% | $21.37M-14.6% | $25.02M+9.7% | $22.81M+0.6% | |
| Service | $56.14M-6.5% | $60.05M-25.3% | $80.4M-2.4% | $82.38M-2.5% | $84.52M+10.8% | |
| Revenue by Geography | ||||||
| CL | $14.87M-14.9% | $17.48M+21.7% | $14.36M-10.3% | $16M+10.1% | $14.53M-9.1% | |
| ES | $8.05M+11.4% | $7.22M+14.0% | $6.34M-5.8% | $6.72M+4.4% | $6.44M-5.4% | |
| IE | $9.68M-56.2% | $22.1M+83.0% | $12.08M+2.9% | $11.74M+114% | $5.48M-69.2% | |
| IL | $0-100% | $171K+22.1% | $140K+0.7% | $139K+90.4% | $73K-92.5% | |
| MX | $6.94M+10.9% | $6.26M-7.1% | $6.74M+7.0% | $6.3M+1.1% | $6.23M+18.7% | |
| Other Countries | $1.15M-1.1% | $1.17M+6.7% | $1.09M+7.5% | $1.02M+2.6% | $992K+6.3% | |
| US | $83.5M-11.2% | $94.05M-15.2% | $110.92M-3.4% | $114.88M-1.1% | $116.21M-14.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Opko Health break its business down?
- Opko Health (OPK) reports gross profit by business across 2 parts — Diagnostics and Pharmaceutical. Each is extracted from the segment footnotes and tracked over time.
- Where does Opko Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Opko Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
